Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 32Carcinoma, Hepatocellular 22Carcinoma, Non-Small-Cell Lung 16Small Cell Lung Carcinoma 11Ovarian Neoplasms 11Colorectal Neoplasms 11Sarcoma 9Lung Neoplasms 9Nasopharyngeal Carcinoma 7Neoplasms 6Breast Neoplasms 6Triple Negative Breast Neoplasms 5Head and Neck Neoplasms 5Glioma 5Esophageal Neoplasms 5Cholangiocarcinoma 5Recurrence 4Pancreatic Neoplasms 4Osteosarcoma 4Esophageal Squamous Cell Carcinoma 4Biliary Tract Neoplasms 4Advanced Gastric Cancer 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Solid Tumor 3Neoplasm Metastasis 3NSCLC 3Melanoma 3Gastrointestinal Neoplasms 3

Interventions

Folfox protocol 3Fluorouracil 3Drug Therapy 3Cisplatin 3apatinib 2anlotinib 2Paclitaxel 2Oxaliplatin 2Leucovorin 2Capecitabine 2Bevacizumab 2sintilimab 1pyrotinib 1pemigatinib 1huachansu 1donafenib 1Trastuzumab 1Sorafenib 1Radiotherapy 1Physical Conditioning, Human 1Microspheres 1Irinotecan 1Immune Checkpoint Inhibitors 1Docetaxel 1Chemoradiotherapy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Digestive System Neoplasms × apatinib × Clear all
NCT03889626 2019-03-26

The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer

Fudan University

Phase 3 Unknown
242 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Stomach Diseases, Stomach Neoplasms

NCT03271255 2019-01-23

Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Shenzhen People's Hospital

Phase 2 Unknown
80 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡